DelveInsight Blogs Sitemap

All Posts in this category
S.No. Product Name Actions
1 Healthcare Data Breach: What it Means for Companies and the Consumer? Visit Post
2 How Healthcare Apps are Adding New Perspectives to the Healthcare Industry? Visit Post
3 Analyzing the Prospects of Drones in Healthcare Delivery System Visit Post
4 New Approaches and Evolutions to Reshape the Diabetes Management and Care Visit Post
5 Technological Innovation: The Medicine of Healthcare Visit Post
6 Mounting Prevalence of Neurological Disorders and the Key Companies Bidding to Solve the Riddle Visit Post
7 Analyzing the Implication of Musculoskeletal Disorders and the Key Companies in the Therapeutics Market Visit Post
8 Leading Autoimmune Diseases to Undergo Robust Improvement in Treatment by Major Pharma Companies Visit Post
9 Key Pharma Companies Expanding their Arm in the Skin Cancer Segment Visit Post
10 Charting out the COVID-19 Vaccine Landscape Visit Post
11 Wearable Devices: Weighing the Potential Benefits and Pitfalls of the Innovative Wearable Products Visit Post
12 Does the use of Assistive Technologies in Autism Spectrum Disorder Payoff? Visit Post
13 How Pharmaceutical Companies Are Mitigating The Gap In The Eye Disorders Treatment Market Visit Post
14 Migraine Market: How Pharma Companies are trying to Uncomplicate the Disease and Bring in Novel Therapies Visit Post
15 Diagnosis Delays, Ineffective Treatment Options Plaque the Bone Cancer Market Growth Visit Post
16 Alarming Growth of Chronic Respiratory Diseases (CRDs) and Their Prolonged Impact on the Quality of Life Visit Post
17 The Rising Burden of Substance Use Disorder And The Treatment Scenario Visit Post
18 Asthma: Rising Prevalence And The Key Challenges In The Management Visit Post
19 How Is Osteoporosis Impacting The Quality Of Life? Visit Post
20 Understanding The Increasing Prevalence Of Diabetes And Its Complications Visit Post
21 Which Pharma Companies are Working to Mitigate the Burden of Digestive Disorders? Visit Post
22 Sleep Disorders: An Emerging Public Health Issue Visit Post
23 How Depression Is Eroding The Mental And The Physical Health Of The Society? Visit Post
24 How Fitness Trackers Are Shaping the Future of Healthcare? Visit Post
25 Bleeding Disorders: How Key Companies Are Shaping The Bleeding Disorders Therapeutics Market? Visit Post
26 Diagnosing At-Home: Are At-Home Diagnostic Tools The New Trends? Visit Post
27 Applications of AI in Healthcare: COVID-19 and Beyond Visit Post
28 How Robots Are Introducing A New Dimension To Healthcare Service Delivery Visit Post
29 Healthcare in 2021: Top Disruptions Bound To Impact The Way Healthcare Is Delivered Visit Post
30 Progeria: The Rarest Case of Premature Ageing Visit Post
31 Why Empathy Is More Important Today In Corporate Culture Than Ever? Visit Post
32 Fake News In The Healthcare Sector: A Misinformation Crisis In The Era Of Digitalization Visit Post
33 Eating Disorders: What Happens When Stigma And Misconceptions Command The Health Visit Post
34 The Burden And The Impact Of Mental Health Issues In Today’s Time Visit Post
35 The Obesity Pandemic: What can we do about it? Visit Post
36 Medical Tourism: Road to Affordable and Quality Medical Care Visit Post
37 Alcohol Use Disorder (AUD): When Drinking Becomes A Headache Visit Post
38 8 Of The Most Common Foods Allergies - Do You Have One? Visit Post
39 A Globally Rising Burden of Sexually Transmitted Diseases (STDs) Visit Post
40 Will Wearable Devices be Streamlined in Healthcare? Visit Post
41 Bioterrorism: A Threat To The Healthcare And Global Peace Visit Post
42 Lung Cancer and its Increasing Global Burden Visit Post
43 Is Subscription Model Going to be the New Normal for Healthcare Industry? Visit Post
44 How Will Artificial Intelligence Change The Future Of Healthcare? Visit Post
45 Adding Value to the Health with a Value-Based Healthcare Model Visit Post
46 Understanding The Disparities In The Healthcare Sector Visit Post
47 How do we curb the Opioid Epidemic? Visit Post
48 Charting Out the Key Drivers and Barriers Influencing Telehealth Adoption in Healthcare Visit Post
49 How Are Chatbots Improving Healthcare Service Delivery? Visit Post
50 The State of Alternative Medicine In The Healthcare Visit Post
51 Healthcare Delivery System: What lies in the future? Visit Post
52 Social Determinants of Health Goes Beyond Just Healthcare Visit Post
53 Nutrition Intervention: Foods to take and foods to avoid when suffering from Gastroparesis Visit Post
54 Boehringer Ingelheim; Roche demonstrated new analyses of their drugs in patients with ILDs during the American Thoracic Society (ATS) Virtual conference Visit Post
55 Merck; Bayer; Shionogi set to showcase their candidates indicated for Chronic RefractoryCough in the ATS Virtual Conference Visit Post
56 Recognising The Warning Signs Of ADHD Visit Post
57 In The Global Race For The COVID-19 Vaccine, India Stands As A Strong Player Visit Post
58 What are the Top Five Leading Causes of Deaths in the World? Visit Post
59 The Most Promising COVID-19 Vaccine Candidates In The Pipeline To Watch Out For Visit Post
60 Can Alzheimer's be cured with Marijuana? Visit Post
61 The Question That Remains Unanswered: What Might Be Causing Alzheimer’s? Visit Post
62 What are the 10 early signs of Alzheimer’s that are overlooked? Visit Post
63 Will there be a second wave of coronavirus? Visit Post
64 Potential Diagnostic solutions that may significantly contribute to COVID-19 detection Visit Post
65 Cardiovascular Disease: A major cause of health loss and a global burden Visit Post
66 Potential of Digital therapeutics and increasing CVDs Visit Post
67 Polypills: Can they offer a potential approach to treat CVDs? Visit Post
68 National Influenza Vaccination Week Visit Post
69 Novel treatment approval promises a better future for Sickle cell disease patients Visit Post
70 Antimicrobial resistance crisis: A global need for antibiotic awareness Visit Post
71 Beta-Thalassemia Pharmacological Therapies Visit Post
72 Non-small cell lung cancer emerging therapies Visit Post
73 The growing size of Sanfilippo syndrome Market: Drivers and Barriers Visit Post
74 Geographic Atrophy Treatment Market: Novel Therapies to Enter the Market Visit Post
75 Biogen seeks the FDA approval to revive its Alzheimer’s drug Aducanumab Visit Post
76 Incyte Corporation submits positive results of trials for its drug Ruxolitinib in GvHD Visit Post
77 Global Burden of Liver cancer: Is it rising?  Visit Post
78 Batten Disease Market: Barriers and Growth Opportunities Visit Post
79 Cystic Fibrosis Drug Market: Emerging drugs that may improve lung infections Visit Post
80 Hyperthyroidism Treatment Market and Drugs Visit Post
81 FDA approves Ibsrela to reduce the global burden of Irritable Bowel Syndrome Visit Post
82 Driving factors boosting the Hepatocellular Carcinoma Market Visit Post
83 FDA approves Non-Controlled treatment for Excessive Daytime Sleepiness Visit Post
84 HIV Treatment Landscape and A New Approach Visit Post
85 Frightening Surge in HIV-drug Resistance: The Biggest Challenge Ahead Visit Post
86 Idiopathic Pulmonary Fibrosis Market Landscape and Forecast Visit Post
87 Is it Okay to take Antibiotics without a prescription? Visit Post
88 Is Parainfluenza virus contagious? Visit Post
89 EMDR Therapy- Is it really that good? Visit Post
90 Teplizumab delays the progression of Type 1 Diabetes Visit Post
91 Lilly overtakes rivals with its Cluster Headache approval Visit Post
92 Origins of the depressive behaviour in Huntington's disease Visit Post
93 Meet the World's most expensive drug: Zolgensma Visit Post
94 Off-label therapies dominate NASH Market Share Visit Post
95 Beware! Season of Lyme has come Visit Post
96 Antitrypsin Deficiency Pipeline Visit Post
97 European Commission gives a nod to Zynquista for type 1 diabetes in adults Visit Post
98 Can Spinal Muscular Atrophy be treated by Protease Inhibitors? Visit Post
99 The promising Pipeline for Gene Therapy In Oncology Visit Post
100 Alzheimer's drug fails! Is it time to move on? Visit Post
101 Japan has got new ways to treat corneas Visit Post
102 Welcome the Slumber Visit Post
103 FDA just lost a gem as Scott Gottlieb resigns Visit Post
104 A helping hand in treatment of CRC Visit Post
105 CRISPR proves to be a blessing for LASSA fever Visit Post
106 The antidepressant drug gets support from FDA Visit Post
107 Relation between gut microbes and depression bolstered Visit Post
108 ‘Software’ differences between humans and monkeys Visit Post
109 Virtual Reality Maps Helps Doctors Understand Cancer Tumor Structure Visit Post
110 Highly mutated cancers respond better to immune therapy Visit Post
111 Triple Negative Breast Cancer Responds to TINAGL Therapy Visit Post
112 Machine Learning Models to Help Predicting Cancer Symptoms, Plan Treatment Visit Post
113 How Neanderthal DNA might have shaped some human brains Visit Post
114 66 Year Ohio Woman Becomes Cancer Free, Thanks to CAR T Cell Therapy Visit Post
115 Now, Artificial Intelligence to Accurately Identify Cancer Cells Visit Post
116 Gold Nanoparticles May Soon Treat Prostate Cancer Visit Post
117 Cancer Cells Trick Body’s Immunity to Survive against Treatment Visit Post
118 Breakthrough Device Designation granted to the AI Software for CTEPH Visit Post
119 Scientists Now Target Attacking Evolution Process of Cancer Cells Visit Post
120 Sleeping at Workplaces: Re-energizing Formula or OSA Disease? Visit Post
121 Chemotherapy as a treatment for Cancer?  Visit Post
122 Virus, the Cancer Therapy of the Future Visit Post
123 150 Year Old Drug Indicates Potential of Future Cancer Therapy Visit Post
124 The risk of solid cancer after chemotherapy Visit Post
125 Drugmakers will now have to reveal medicine prices in television ads Visit Post
126 Is Gene Therapy the Next Cancer Treatment Revolution?  Visit Post
127 The novel therapy for brain cancer treatments Visit Post
128 Antidepressants withdrawal hits millions of people Visit Post
129 Companion Diagnostics Visit Post
130 Researchers Turn towards Light to Solve Lung Cancer Puzzle Visit Post
131 Snippet Visit Post
132 Pancreatic Cancer Treatment to Stride Beyond Chemotherapy Visit Post
133 Snippet Visit Post
134 Now, Nanoparticles for Cancer Treatment Visit Post
135 SNIPPET Visit Post
136 Orphan Drug Act and Its Criticism Visit Post
137 Snippet Visit Post
138 Snippet Visit Post
139 Snippet : Genetic Mutation Visit Post
140 Snippet : Migraine Visit Post
141 Snippets : Parkinson Visit Post
142 Snippet : Endometriosis Visit Post
143 Snippet : Acute lymphoblastic leukemia Visit Post
144 Predicting risk of Acute Myeloid Leukemia (AML) in healthy individuals Visit Post
145 Parkinson's and tuberculosis shares a common protein that could provide better drugs for both Visit Post
146 Potential cure for Common cold Visit Post
147 Takeda buys Shire in a deal worth USD 62 billion Visit Post
148 Takeda acquisition on Shire raises its share by 25 percent Visit Post
149 New method for classification of CNS tumors Visit Post
150 Cholesterol drug Praluent successful in reducing heart risk Visit Post
151 Snippet: M&A activities of big pharma’s will fuel CAR-T cell therapy Visit Post
152 Gilead Sciences  launched a highly effective hepatitis C drug Sovaldi Visit Post
153 In vivo monitoring of T cell–dendritic cell interactions by intercellular enzymatic labelling Visit Post
154 Snippet Visit Post
155 Snippet Visit Post
156 Ketamine to work in mice Visit Post
157 Chemists may help solve the air-pollution health crisis Visit Post
158 'Killer' Mosquito to be released in 20 US states to fight mosquitoes Visit Post
159 Publishers collaborate to remove journal articles from ResearchGate Visit Post
160 South Korean researchers influencing lift of human-embryo restrictions Visit Post
161 Cancer Globally (Vol. 1, Issue 1) Visit Post
162 Reprogrammed cells relieve Parkinson's symptoms in trials Visit Post
163 Social Behavior Loss Observed in Gene-edited ants through CRISPR Visit Post
164 Genetically Engineered Salmon : Are you up for dinner? Visit Post
165 Innovate the UK, aiming to drive efforts to commercialize research Visit Post
166 Georgia physician to lead US public-health agency Visit Post
167 Elsevier Granted millions in damages from Sci-Hub by US Court Visit Post
168 China cracks down on fake peer reviews Visit Post
169 New cancer drug tested in mice may benefit certain leukaemia patients Visit Post
170 Gut bacteria can stop cancer drugs from working Visit Post
171 Bio-manufacturing with Spider Silk for pre-term babies Visit Post
172 FDA grants accelerated approval to pembrolizumab Visit Post
173 Geneticists enlist engineered virus & CRISPR to battle citrus disease Visit Post
174 Scientists relieved by Emmanuel Macron’s French election victory Visit Post
175 World Ovarian Cancer Day Visit Post
176 Science wins reprieve in US budget deal Visit Post
177 Cord Blood makes brains of elderly mice young again Visit Post
178 The Snippet: Targeting metabolism in Renal Cell Carcinoma Visit Post
179 Whitepaper: Impact of Brexit on Pharma Space Visit Post
180 CRISPR finds faults in previous researches Visit Post
181 A Probiotic drink from the gut microbiome of an elite athlete Visit Post
182 DNA typos to blame for most Cancer Mutations Visit Post
183 South Korea’s scientists seek change amid political chaos Visit Post
184 New biomarkers improve standard screening in Pancreatic Cancer Visit Post
185 New biomarkers for screening in Pancreatic Cancer Visit Post
186 The Snippet - What Trump’s new travel ban means for science? Visit Post
187 Antibiotic Resistance: The Big Challenge of Healthcare Industry Visit Post
188 Hepatitis C drugs re-energize global fight over patents Visit Post
189 The Snippet: Delay in hiring science advisers intensifies Brexit worries Visit Post
190 Diminishing pipeline of Galectin Inhibitors Visit Post
191 TRAIL Receptor Agonists: Emerging target therapies against Cancer Visit Post
192 OncoTrack develops new biomarkers for colon cancer Visit Post
193 Familial Adenomatous Polyposis (FAP): A cataclysmic genetic mutation Visit Post
194 Chronic Kidney Disease: Complex Debilitating Condition Visit Post
195 Clinical trials need to assess drug efficacy before trials Visit Post
196 Chronic Obstructive Pulmonary Disorder Visit Post
197 Statistical Insight on Some Common Cancers Visit Post
198 Can the brain detect Addictive cravings even after death? Visit Post
199 BioAsia 2017 Visit Post
200 Happy Republic Day !!! Visit Post
201 Subtypes of cervical cancer identified Visit Post
202 Prostate Cancer: Metastases leading to increased incidence in the USA Visit Post
203 Warm Wishes for Lohri Visit Post
204 Pulling the apoptotic trigger for necrosis Visit Post
205 Fatal French clinical trial failed to check data before raising dose Visit Post
206 Warm Greetings from DelveInsight! Visit Post
207 DelveInsight's Discount on Market Research Reports! Visit Post
208 Merry Christmas Visit Post
209 Pharma M&A Rebound May Take a While in 2017 Visit Post
210 US drug approvals plummet in 2016 Visit Post
211 Anterior Uveitis: A Vision-threatening condition Visit Post
212 Mexico's Human-Embryo Research on Tenterhooks Visit Post
213 The next generation of 'weaponized antibody' therapies Visit Post
214 NgAgo gene-editing, claiming to be a better alternative to CRISPR gene editing, falls into a controversy in peer-reviewed papers Visit Post
215 Hurry Up! Grab the latest discount offer... Visit Post
216 CRISPR gene-editing tested in a person for the first time Visit Post
217 Donald Trump's US election win stuns scientists Visit Post
218 Meet DelveInsight in BioEurope '16 Visit Post
219 DelveInsight Wishes you a Prosperous Diwali! Visit Post
220 Autism study finds early intervention has lasting effects Visit Post
221 Do we need to revise human genetics? Visit Post
222 The Global M&A Frenzy Drops in the 3rd Quarter Visit Post
223 The Snippet: The Success of Cannabidiol Visit Post
224 Merck Focuses its Research on Hard to Treat Cancers Visit Post
225 FDA Approves Sarepta’s Muscular Dystrophy Drug after Months of Debate Visit Post
226 PI3Kγ- a molecular switch that controls immune suppression Visit Post
227 HER2 Expression and its Dynamic Functional States Visit Post
228 Novel Genetics Biomarker found by a Group of Researchers May Offer Novel Treatment Approach for Cancer Visit Post
229 AstraZeneca’s new Asthma Drug Aces Phase III trial Visit Post
230 Identity Crises Faced by a Venerable Brain-Cancer Cell Line Visit Post
231 The Road Less Travelled: EpiPen's Pricing Policy Visit Post
232 Denali's Impressive Research Portfolio Visit Post
233 The Curious Case of CRISPR Technology Visit Post
234 Collaboration provides new insight into cancer treatment Visit Post
235 Turning your own skin cells into cancer-killing machines Visit Post
236 DelveInsight: One Year Anniversary! Visit Post
237 Delveinsight launched novel Drug Pipeline reports Visit Post
238 Successful Launch of Mechanism of Action Based Pipeline Reports Visit Post